BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37735617)

  • 21. When used together SS18-SSX fusion-specific and SSX C-terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most cases.
    Zaborowski M; Vargas AC; Pulvers J; Clarkson A; de Guzman D; Sioson L; Maclean F; Chou A; Gill AJ
    Histopathology; 2020 Oct; 77(4):588-600. PubMed ID: 32559341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic ConFUSION: SS18-SSX Fusion Rewires BAF Complex to Activate Bivalent Genes in Synovial Sarcoma.
    Morgan MA; Shilatifard A
    Cancer Cell; 2018 Jun; 33(6):951-953. PubMed ID: 29894696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The C terminus of the synovial sarcoma-associated SSX proteins interacts with the LIM homeobox protein LHX4.
    de Bruijn DR; van Dijk AH; Willemse MP; van Kessel AG
    Oncogene; 2008 Jan; 27(5):653-62. PubMed ID: 17667940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel SS18-SSX Fusion-specific Antibody for the Diagnosis of Synovial Sarcoma.
    Baranov E; McBride MJ; Bellizzi AM; Ligon AH; Fletcher CDM; Kadoch C; Hornick JL
    Am J Surg Pathol; 2020 Jul; 44(7):922-933. PubMed ID: 32141887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.
    Carmody Soni EE; Schlottman S; Erkizan HV; Uren A; Toretsky JA
    Clin Orthop Relat Res; 2014 Mar; 472(3):874-82. PubMed ID: 23716114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma.
    Brien GL; Remillard D; Shi J; Hemming ML; Chabon J; Wynne K; Dillon ET; Cagney G; Van Mierlo G; Baltissen MP; Vermeulen M; Qi J; Fröhling S; Gray NS; Bradner JE; Vakoc CR; Armstrong SA
    Elife; 2018 Nov; 7():. PubMed ID: 30431433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma.
    Kawano S; Grassian AR; Tsuda M; Knutson SK; Warholic NM; Kuznetsov G; Xu S; Xiao Y; Pollock RM; Smith JS; Kuntz KK; Ribich S; Minoshima Y; Matsui J; Copeland RA; Tanaka S; Keilhack H
    PLoS One; 2016; 11(7):e0158888. PubMed ID: 27391784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics.
    Su L; Sampaio AV; Jones KB; Pacheco M; Goytain A; Lin S; Poulin N; Yi L; Rossi FM; Kast J; Capecchi MR; Underhill TM; Nielsen TO
    Cancer Cell; 2012 Mar; 21(3):333-47. PubMed ID: 22439931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlating SS18-SSX immunohistochemistry (IHC) with SS18 fluorescent in situ hybridization (FISH) in synovial sarcomas: a study of 36 cases.
    Tay TKY; Sukma NB; Lim TH; Kuick CH; Goh JY; Chang KTE
    Virchows Arch; 2021 Oct; 479(4):785-793. PubMed ID: 34091760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent TRPS1 expression in synovial sarcoma is associated with SS18-SSX fusion oncoprotein activity.
    Cloutier JM; Ingram DR; Wani K; Lazar AJ; Wang WL
    Hum Pathol; 2022 Dec; 130():88-94. PubMed ID: 36162599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential roles of SS18-SSX fusion gene and insulin-like growth factor-1 receptor in synovial sarcoma cell growth.
    Törnkvist M; Natalishvili N; Xie Y; Girnita A; D'Arcy P; Brodin B; Axelson M; Girnita L
    Biochem Biophys Res Commun; 2008 Apr; 368(3):793-800. PubMed ID: 18267106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nucleosome acidic patch and H2A ubiquitination underlie mSWI/SNF recruitment in synovial sarcoma.
    McBride MJ; Mashtalir N; Winter EB; Dao HT; Filipovski M; D'Avino AR; Seo HS; Umbreit NT; St Pierre R; Valencia AM; Qian K; Zullow HJ; Jaffe JD; Dhe-Paganon S; Muir TW; Kadoch C
    Nat Struct Mol Biol; 2020 Sep; 27(9):836-845. PubMed ID: 32747783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic Targets in Synovial Sarcoma: A Mini-Review.
    Hale R; Sandakly S; Shipley J; Walters Z
    Front Oncol; 2019; 9():1078. PubMed ID: 31681608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SS18-SSX Expression in a Contemporary Cohort of Primary Renal Synovial Sarcoma: A Multi-Institutional Experience of Fourteen Patients.
    Challa B; Mohanty SK; Jha S; Sampat NY; Sardana R; Lobo A; Sharma S; Arora S; Rath D; Munjal G; Pattnaik N; Jain D; Jain E; Dewan A; Dixit M; Malik V; Shinde S; Balzer BL; Parwani A
    Int J Surg Pathol; 2023 Oct; 31(7):1232-1243. PubMed ID: 36591871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SS18-SSX2 and the mitochondrial apoptosis pathway in mouse and human synovial sarcomas.
    Jones KB; Su L; Jin H; Lenz C; Randall RL; Underhill TM; Nielsen TO; Sharma S; Capecchi MR
    Oncogene; 2013 May; 32(18):2365-71, 2375.e1-5. PubMed ID: 22797074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel FISH assay for SS18-SSX fusion type in synovial sarcoma.
    Surace C; Panagopoulos I; Pålsson E; Rocchi M; Mandahl N; Mertens F
    Lab Invest; 2004 Sep; 84(9):1185-92. PubMed ID: 15208645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma.
    Amary MF; Berisha F; Bernardi Fdel C; Herbert A; James M; Reis-Filho JS; Fisher C; Nicholson AG; Tirabosco R; Diss TC; Flanagan AM
    Mod Pathol; 2007 Apr; 20(4):482-96. PubMed ID: 17334349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoreactivity of a Monoclonal Antibody to SS18-SSX Fusion Gene Product in Formalin-fixed Paraffin-embedded Synovial Sarcoma Tissue Section.
    Saigo C; Kito Y; Takeuchi T
    Appl Immunohistochem Mol Morphol; 2018 Mar; 26(3):206-211. PubMed ID: 27362474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fusions of the SYT and SSX genes in synovial sarcoma.
    Ladanyi M
    Oncogene; 2001 Sep; 20(40):5755-62. PubMed ID: 11607825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SS18-SSX-regulated miR-17 promotes tumor growth of synovial sarcoma by inhibiting p21WAF1/CIP1.
    Minami Y; Kohsaka S; Tsuda M; Yachi K; Hatori N; Tanino M; Kimura T; Nishihara H; Minami A; Iwasaki N; Tanaka S
    Cancer Sci; 2014 Sep; 105(9):1152-9. PubMed ID: 24989082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.